The next iteration of the Prescription Drug User Fee Act will be a landmark moment for the 35-year-old program because for the first time, the US FDA and industry agreed to do less.
The next iteration of the Prescription Drug User Fee Act will be a landmark moment for the 35-year-old program because for the first time, the US FDA and industry agreed to do less.